Last month, EMA published its overview of key recommendations for 2020 on the authorisation and safe...
Read moreFollowing Brexit, the Medicines and Healthcare Regularoty Agency (MHRA) has become the UK's sole bod...
Read moreFor an audience to properly understand the value of a drug, evidence needs to be put into context.
Read moreThe Patented Medicine Prices Review Board (PMPRB) has a mandate to ensure that patented medicines ar...
Read moreOur experts predict the 5 trends they think will dominate the European pricing and market access lan...
Read moreCell and gene therapies - life saving opportunity for many patients
Read moreA recent study assessed whether this new process has resulted in faster patient access.
Read more... and the use of financial arrangements for new oncology and non-oncology drugs?
Read moreThe UK will continue to adopt decisions taken by the European Commission on the approval of new mark...
Read moreWhen critically appraising a clinical study, it is key to firstly identify the sources of uncertaint...
Read more